Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
Ultragenyx Pharmaceutical has received accelerated approval from the FDA for its gene therapy, Genglycos, to treat GSDIa.
Read Full Article
Pharma Tech
SandboxAQ introduces AQPotency for virtual drug screening
SandboxAQ has introduced AQPotency, a LQM designed to virtually screen and predict the potential of drug candidates without the need for a solved protein structure.
Read Full Article
Express Pharma
Glenmark receives USFDA approval for Fluticasone Propionate Nasal Spray
Fluticasone Propionate Nasal Spray USP is bioequivalent and therapeutically equivalent to Flonase Nasal Spray The post Glenmark receives USFDA approval for Fluticasone Propionate Nasal Spray appeared first on Express Pharma.
Read Full Article
Express Pharma
Strides Pharma receives USFDA EIR for Bengaluru facility
USFDA classifies inspection outcome as Voluntary Action Indicated following May 2026 cGMP inspection The post Strides Pharma receives USFDA EIR for Bengaluru facility appeared first on Express Pharma.
Read Full Article
Express Pharma
Mankind Pharma inks agreement for two insulin analogues in India
Partnership with Chongqing Chenan Biopharmaceutical covers Insulin Degludec and Insulin Degludec + Aspart Combination The post Mankind Pharma inks agreement for two insulin analogues in India appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Aug 20, 2026, 10:30 AM
Lupin and Tenpoint Therapeutics Partner to Commercialize YUVEZZI in Key European Markets for Presbyopia
Shots: Ref:Â Lupin | Image:Â Lupin & Tenpoint| Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com The post Lupin and Tenpoint Therapeutics Partner to Commercialize YUVEZZI in Key European Markets for Presbyopia appeared first on PharmaShots.
ET Pharma
Aug 20, 2026, 10:01 AM
Lupin licenses Tenpoint Therapeutics’ presbyopia therapy Europe market rights
Under the agreement, Lupin’s wholly owned subsidiary VISUfarma will make a strategic investment in Visus and the company will also be eligible to receive regulatory and commercial milestone payments, as well as tiered royalties based on net sales.
Pharma Tech
Aug 20, 2026, 9:40 AM
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
Ultragenyx Pharmaceutical has received accelerated approval from the FDA for its gene therapy, Genglycos, to treat GSDIa.
Pharma Tech
Aug 20, 2026, 8:51 AM
SandboxAQ introduces AQPotency for virtual drug screening
SandboxAQ has introduced AQPotency, a LQM designed to virtually screen and predict the potential of drug candidates without the need for a solved protein structure.
PharmaShots
Aug 20, 2026, 8:30 AM
Tolerance Bio Licenses Efineptakin Alfa from NeoImmuneTech to Advance Thymic Function and Immune Resilience Programs
Shots: Ref:Â Tolerance Bio | Image:Â Tolerance Bio | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com The post Tolerance Bio Licenses Efineptakin Alfa from NeoImmuneTech to Advance Thymic Function and Immune Resilience Programs appeared first on PharmaShots.
ET Pharma
Aug 20, 2026, 8:13 AM
Mankind licenses Insulin Degludec and Aspart combo from China’s Chenan Bio
The licensed drugs are alternatives to Novo Nordisk’s Tresiba and Ryzodeg. Both biosimilar therapies have completed their Phase 3 studies in China.
News
Latest industry coverage
Google News
Aug 20, 2026, 10:30 AM
Italy’s $10 Billion Pharma Family Makes A U.S. Power Move - Forbes
Italy’s $10 Billion Pharma Family Makes A U.S. Power Move  Forbes
Google News
Aug 20, 2026, 10:17 AM
Danish firm Novonesis to roll out â‚ą3,000 crore Maharashtra investment over 2-3 years - The Economic Times
Danish firm Novonesis to roll out ₹3,000 crore Maharashtra investment over 2-3 years  The Economic Times
Google News
Aug 20, 2026, 10:15 AM
FDA to host workshop for companies exploring the GLP-1 generic drug pathway - PharmaLive
FDA to host workshop for companies exploring the GLP-1 generic drug pathway  PharmaLive
Google News
Aug 20, 2026, 10:14 AM
PharmaTech Expo brings together over 450 exhibitors, 10,000 products in Gandhinagar - The Tribune
PharmaTech Expo brings together over 450 exhibitors, 10,000 products in Gandhinagar  The Tribune
Google News
Aug 20, 2026, 10:05 AM
Job losses, plant closures spark talks on future of SA’s pharmaceutical industry - Business Day
Job losses, plant closures spark talks on future of SA’s pharmaceutical industry  Business Day
Google News
Aug 20, 2026, 10:03 AM
The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi - Pharmaceutical Executive
The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi  Pharmaceutical Executive
Google News
Aug 20, 2026, 10:01 AM
Lab 4.0 balance: connected, compliant and ready to integrate - European Pharmaceutical Review
Lab 4.0 balance: connected, compliant and ready to integrate  European Pharmaceutical Review
Google News
Aug 20, 2026, 9:37 AM
IFC, Popular Pharmaceuticals Partner to Boost Bangladesh’s Healthcare Supply Chains and Create Jobs - fundsforNGOs News
IFC, Popular Pharmaceuticals Partner to Boost Bangladesh’s Healthcare Supply Chains and Create Jobs  fundsforNGOs News
Google News
Aug 20, 2026, 9:18 AM
Pharmaceutical production compliance burdens nobody talks about - Cleanroom Technology
Pharmaceutical production compliance burdens nobody talks about  Cleanroom Technology
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer